Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life─threatening infectious diseases,...

June 27, 2024 -- The National Institutes of Health (NIH) is sponsoring a clinical trial to evaluate the safety of an investigational monoclonal...

Checkpoint inhibitor therapies release the immune system's molecular "brakes," removing protein barriers that hinder its ability to detect and...

Biologics are a cornerstone of modern medicine, offering groundbreaking treatments for a wide range of diseases, including cancer, autoimmune...

With a $300,000 grant, the Welch Foundation is supporting University of Texas at Arlington research into creating new materials to safely and...

A recent study has illuminated a significant relationship between vitamin B12 levels and chronic inflammation, a culprit behind several severe health...

Competitive: Charles River Laboratories - Scotland: For 75 years, Charles River employees have worked together to assist in the discovery,...

CAMBRIDGE, Mass.--(BUSINESS WIRE) June 28, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced...

CDR─Life Inc, a global company developing powerful T─cell engagers (TCE) to eradicate hard─to─treat solid tumors, has announced an expansion...

In recent years, advancements in medical research have led to the development of targeted therapies for various cancers, offering new hope for...